Thoracic Pathology Course 2023

This two-and-a-half-day course is designed to give a current review of thoracic pathology with clinical, radiologic, and molecular correlations. The program will consist of a series of presentations, including some multidisciplinary sessions, on lung cancer, interstitial lung disease, and non-neoplastic lung disease.

Updates on the 2021 WHO Classification of Lung Tumors, the 8th Edition TNM Staging Classification, the ATS/ERS Classification of Idiopathic Interstitial Pneumonias, and Guidelines for Diagnosis of Hypersensitivity Pneumonitis will be presented. Most speakers will be expert lung pathologists, but there will also be clinical and radiologic presentations by well-known thoracic clinicians and radiologists. The presentations will illustrate the importance of a multidisciplinary approach to solving difficult problems in thoracic disease.

This program is co-sponsored with Massachusetts General Hospital and endorsed by the Pulmonary Pathology Society.

In-person or Virtual

Join us in person, September 29th through October 1st, 2023, on the campus of Memorial Sloan Kettering Cancer Center on the Upper East Side of Manhattan, a vibrant and safe neighborhood within easy access of the widely varied cultural attractions of New York City. A virtual option is also available for those unable to join us in person.

Online Syllabus

Registered attendees will receive access to an online syllabus, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course.

Who Should Attend

1. State current concepts in lung, pleural and mediastinal pathology
2. Recall the clinically relevant advances and technology in molecular pathology of lung cancer
3. Define the importance of correlation between clinical, radiologic and pathologic data in diagnosis and management of interstitial lung disease
4. Recognize the significance of lung biopsy and multidisciplinary correlation for the diagnosis of non-neoplastic lung disease with a focus on interstitial pneumonias, hypersensitivity pneumonitis and acute lung injury
5. Comprehend the most recent histologic concepts in lung cancer diagnosis and classification including problematic issues related to spiral CT screening
6. Recognize the differential diagnosis for mediastinal and pleural lesions
7. Describe the usefulness of cytology in pulmonary, pleural and mediastinal diagnoses

Registration Fees (In-person or Virtual)

• Physicians (MDs, DOs, and PhDs): $895
• Pathology Assistants, Fellows, Residents, RNs, and Other Healthcare Providers: $450
• Industry Professionals*: $1550
• MSK Employees: Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts and Complimentary Registration

• Complimentary registration is available for registrants residing in low and lower-middle income countries. Please email [email protected] to receive a promotion code to apply at registration.
• Complimentary registration is available for Massachusetts General Hospital residents and fellows to attend this course. If you are a member of one of these groups, contact [email protected] using your institute's email address to receive a promotion code to apply at registration.
• A discounted rate is available for MSK Alumni and MSK Cancer Alliance members to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for more information or a promotion code.

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

In-person Registration: Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Virtual Registration: The virtual option for this program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, will be sent to virtual registrants via email prior to the start of the Symposium.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 19.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPath CC Recognition Statement

This activity will offer 19.75 Lifelong Learning (CME) credit towards the American Board of Pathology’s Continuing Certification program.

Course Directors 

William D. Travis, MD 
Memorial Sloan Kettering Cancer Center

Mari Mino-Kenudson, MD
Massachusetts General Hospital

Course Co-directors 

Natasha Rekhtman, MD, PhD 
Memorial Sloan Kettering Cancer Center 

Lida Hariri, MD, PhD
Massachusetts General Hospital

Invited Course Faculty 

Mary Beth Beasley, MD 
Mount Sinai 

Alain Borczuk, MD
Northwell Health

Sanja Dacic, MD
Yale School of Medicine

Robert J. Kaner, MD
Weill Cornell

Alan Legasto, MD
Weill Cornell

Andre Moreira, MD
NYU Langone 

Navneet Narula, MD
NYU Langone 

Anjali Saqi, MD
Columbia University

Chen Zhang, MD, PhD
Weill Cornell

MSK Course Faculty 

Marina K. Baine, MD, PhD

Darren J. Buonocore, MD

Jason C. Chang, MD

Mohit Chawla, MD

Michelle S. Ginsberg, MD

James M. Isbell, MD, MSCI

Charles M. Rudin, MD, PhD

Jennifer L. Sauter, MD

Soo Ryum Yang, MD

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.